Company intelligence
Headlands Research
Headlands Research is improving patients’ lives by advancing innovative medical therapies.
About Headlands Research
Headlands Research is a leading globally integrated site organization with a mission to improve patients’ lives by advancing innovative medical therapies. Headlands Research is comprised of the highest quality dedicated and embedded research centers across North America. Our investigators and sites have completed 5,000+ Phase I-IV trials to date in various TA areas including but not limited to Allergy, Cardiovascular, Dermatology, Emergency Medicine, Endocrinology, Family Medicine, Family Practice, Gastroenterology, Immunology, Infectious Disease Prophylaxis and Treatment, Internal Medicine, Nephrology, Neurology. Obstetrics and Gynecology (OB/GYN), Oncology, Ophthalmology, Orthopaedics, Otolaryngology (ENT), Pediatrics, Physical Medicine and Rehabilitation, Plastic Surgery, Preventive Medicine, Psychiatry, Urology and Vaccine.
Verified activity
Signals from Headlands Research
4 published signals
People
Headlands Research welcomed Brandon Pallott as its new Chief Commercial Officer.
Reported by Headlands Research
People
Headlands Research hired Nicole Legler as Director of Strategic Partnerships.
Reported by Nicole Legler
Research & Knowledge
Headlands Research Principal Investigator Pieter Strauss, MD, MBChB, FRCPC, explored emerging approaches to treatment-resistant depression including biomarkers, AI-enabled treatment personalization, glutamate modulators, and psychedelics in an article published by Headlands Research.
Reported by Headlands Research
Presence & Recognition
Headlands Research is attending DPHARM 2026 on September 15-16 and Partnerships with Sites on September 14.
Reported by Headlands Research